Inventor · disambiguated record
Kelli E. Smith
Also filed as: SMITH KELLI E
16 granted patents·13 pending applications·226 citations·filing 1992–2002
94Inventor score
Top patents by PatentIndex Score
29 records- 0180US5658786ADNA encoding rat taurine transporter and uses thereofSYNAPTIC PHARMA CORP·Filed 1993·Granted Aug 19, 1997·38 cites·13 claims
- 0274US6225115B1DNA encoding taurine and GABA transporters and uses thereofSYNAPTIC PHARMA CORP·Filed 1999·Granted May 1, 2001·33 cites·17 claims
- 0373US6329197B2DNA encoding galanin GALR3 receptors and uses thereofSYNAPTIC PHARMA CORP·Filed 1997·Granted Dec 11, 2001·27 cites·33 claims
- 0472US5766848AMethods for identifying compounds which specifically bind a human betaine/GABA transporterSYNAPTIC PHARMA CORP·Filed 1994·Granted Jun 16, 1998·29 cites·8 claims
- 0569US5972624AMethod of identifying ligands which bind recombinant galanin receptor (GALR2)SYNAPTIC PHARMA CORP·Filed 1996·Granted Oct 26, 1999·32 cites·6 claims
- 0665US6287788B1DNA encoding galanin GALR3 receptors and uses thereofSYNAPTIC PHARMA CORP·Filed 1998·Granted Sep 11, 2001·18 cites·16 claims
- 0763US6368812B1Process for determining the agonist or antagonist of galanin receptor (GALR3)SYNAPTIC PHARMA CORP·Filed 1998·Granted Apr 9, 2002·17 cites·15 claims
- 0862US7022489B2Method of using cells expressing galanin receptor 3 (GALR3)LUNDBECK & CO AS H·Filed 2001·Granted Apr 4, 2006·3 cites·18 claims
- 0961US7132248B2Uses of galanin GALR2 receptorsLUNDBECK & CO AS H·Filed 2002·Granted Nov 7, 2006·0 cites·32 claims
- 1057US2003082641A1A method of treating depression using a galr3 receptor antagonistSYNAPTIC PHARMA CORP·Filed 2001·Application pending·0 cites
- 1155US7060449B2Method of preparing GALR2 receptors compositionLUNDBECK & CO AS H·Filed 2002·Granted Jun 13, 2006·0 cites·10 claims
- 1249US5712148ADNA encoding a human betaine/GABA transporter and uses thereofSYNAPTIC PHARMA CORP·Filed 1995·Granted Jan 27, 1998·5 cites·14 claims
- 1349US5559021ADNA encoding a novel mammalian transporter homologous to neurotransmitter transporters and uses thereofSYNAPTIC PHARMA CORP·Filed 1993·Granted Sep 24, 1996·12 cites·15 claims
- 1448US2002198369A1DNA encoding orphan SNORF12 receptorFiled 2002·Application pending·0 cites
- 1548US2003158401A1DNA encoding orphan SNORF13c receptorFiled 2002·Application pending·0 cites
- 1647US2003022839A1Receptor agonists useful for the treatment of painFiled 2002·Application pending·0 cites
- 1747US2003078407A1DNA encoding orphan SNORF53 receptorFiled 2002·Application pending·0 cites
- 1847US2003105317A1DNA encoding orphan SNORF65 receptorFiled 2002·Application pending·0 cites
- 1947US2003124138A1DNA encoding a human receptor (hp15a) and uses thereofFiled 2001·Application pending·0 cites
- 2046US2003023072A1DNA encoding orphan SNORF9 receptorFiled 2002·Application pending·0 cites
- 2146US2003143729A1DNA encoding taurine and GABA transporters and uses thereofSYNAPTIC PHARMA CORP·Filed 2001·Application pending·0 cites
- 2244US2002151704A1DNA encoding orphan SNORF10 receptorFiled 2001·Application pending·0 cites
- 2344US2002151705A1DNA encoding orphan SNORF49 receptorFiled 2001·Application pending·0 cites
- 2444US2002077469A1DNA encoding orphan SNORF11 receptorFiled 2001·Application pending·0 cites
- 2542US6586191B2Method of identifying compounds that bind galanin receptor (GALR2)SYNAPTIC PHARMA CORP·Filed 1997·Granted Jul 1, 2003·4 cites·19 claims
- 2642US2003119096A1Method of treating an abnormality using a GALR3 receptor antagonistFiled 2001·Application pending·0 cites
- 2740US6127131ADNA encoding a glycine transporter and uses thereofSYNAPTIC PHARMA CORP·Filed 1998·Granted Oct 3, 2000·2 cites·8 claims
- 2837US6790656B1DNA encoding galanin GALR2 receptorsSYNAPTIC PHARMA CORP·Filed 1997·Granted Sep 14, 2004·1 cites·40 claims
- 2934US5756348ADNA encoding a glycine transporter and uses thereofSYNAPTIC PHARMA CORP·Filed 1992·Granted May 26, 1998·5 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Kelli E. Smith files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →